GlassScriptPhysician profile
Scott Thomas Bleazey
NPI 1144525973
$11,922.66
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,662 · 2020: $2,084 · 2021: $70.62 · 2022: $657 · 2023: $287 · 2024: $1,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $800 · Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $800.00 |
| Food and Beverage | $649.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maxx Health INC | $7,835.85 | 2019-2024 | Summa Ortho Optossol, Summa Ortho Foot |
| Wright Medical Technology, INC. | $2,579.17 | 2019-2020 | |
| Stryker Corporation | $860.28 | 2019-2024 | Augment Injectable, Vitoss |
| Kerecis Limited | $137.71 | 2022 | |
| Celularity INC. | $125.00 | 2019 | |
| Smith+Nephew, INC. | $117.47 | 2019-2024 | Q-Fix, Footprint, Bone Anchors With Arthroscopic Delivery System |
| Seapearl East, INC | $70.62 | 2021 | |
| Treace Medical Concepts, INC. | $68.96 | 2022-2024 | |
| Bioventus LLC | $57.56 | 2020-2024 | Durolane |
| Biocomposites INC | $29.61 | 2019 | |
| Stimwave Technologies Incorporated | $25.12 | 2019 | |
| Zimmer Biomet Holdings, INC. | $15.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Bleazey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.